BRIEF published on 07/16/2026 at 22:15, 2 months 8 days ago DBV Technologies publie son Rapport Financier Semestriel 2026 Rapport Financier Cotation Boursière DBV Technologies Allergies Alimentaires Technologie VIASKIN
BRIEF published on 07/16/2026 at 22:15, 2 months 8 days ago DBV Technologies publishes its 2026 Half-Year Financial Report Financial Report Stock Market Listing DBV Technologies Food Allergies Viaskin Technology
BRIEF published on 07/16/2026 at 22:15, 2 months 8 days ago DBV Technologies dépose son rapport semestriel 2026 auprès d'AMF. Allergies Alimentaires Rapport Semestriel Dépôt AMF Technologies DBV Patch VIASKIN
PRESS RELEASE published on 07/16/2026 at 22:10, 2 months 8 days ago DBV Technologies publie son Rapport Financier Semestriel 2026 ? Modalités de mise à disposition ou de consultation DBV Technologies publie son Rapport Financier Semestriel 2026 et le rend disponible pour consultation en ligne Investisseurs DBV Technologies Allergies Alimentaires Viaskin Rapport Financier Semestriel 2026
PRESS RELEASE published on 07/16/2026 at 22:10, 2 months 8 days ago DBV Technologies Announces the Filing of its 2026 Half-Year Report ? Conditions for Accessing or Consulting the Report DBV Technologies files 2026 Half-Year Report with French market authority AMF. Company develops treatments for food allergies with VIASKIN patch technology Half-year Report DBV Technologies Food Allergies French Market Authority VIASKIN Patch Technology
BRIEF published on 07/16/2026 at 22:06, 2 months 8 days ago DBV Technologies Releases 2026 Mid-Year Financial Update and Progress Report Financial Results Cash Position Clinical Trials FDA Submission VIASKIN® Peanut Patch
BRIEF published on 07/16/2026 at 22:06, 2 months 8 days ago DBV Technologies publie son rapport financier et d'avancement de mi-année 2026 Résultats Financiers Essais Cliniques Soumission À La FDA Position De Trésorerie Patch VIASKIN® À L'arachide
BRIEF published on 07/16/2026 at 22:06, 2 months 8 days ago DBV Technologies announces its financial results and clinical progress for the first half of 2026 FDA Financial Results DBV Technologies Food Allergies Viaskin® Peanut
BRIEF published on 07/16/2026 at 22:06, 2 months 8 days ago DBV Technologies annonce ses résultats financiers et avancées cliniques pour le premier semestre 2026 Résultats Financiers FDA DBV Technologies Allergies Alimentaires Viaskin® Peanut
Published on 09/25/2026 at 07:30, 4 hours 3 minutes ago Tocvan Reports Positive Closed-Circuit Column Leach Results at Gran Pilar
Published on 09/25/2026 at 00:30, 11 hours 3 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 11 hours 18 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 13 hours 32 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/25/2026 at 10:00, 1 hour 33 minutes ago AI and supply chains open new pathways to systemic stress as risks become more interconnected, find Swiss Re Institute and LSE
Published on 09/25/2026 at 09:09, 2 hours 24 minutes ago flatexDEGIRO sets course for next phase of growth
Published on 09/25/2026 at 09:08, 2 hours 25 minutes ago EQS-Adhoc: flatexDEGIRO expands Management Board
Published on 09/25/2026 at 07:00, 4 hours 33 minutes ago ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 17 hours 2 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 17 hours 33 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 17 hours 33 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
